Items tagged with Drug-resistant TB
MSF issue brief: Ready, set, slow down (post with simple image)
New and promising DR-TB drugs are grabbing headlines but not reaching patients.
Why are rates of drug-resistant TB so high in Russia? (post with simple image)
Natalya, 31, from Saint Petersburg, is being treated for a new and virulent form of an ancient disease ravaging Russia.
MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week (post with simple image)
Lack of political commitment will jeopardize momentum for stronger TB action across the region.
MSF’s DR-TB report proves 'decentralised' model is better, more cost effective (post with simple image)
The decentralised model is aimed at diagnosing and treating the majority of DR-TB patients in primary health clinics, instead of being required to be hospitalised for up to six months.
The bedaquiline donation program started on April 1 (post with simple image)
A webinar, explaining the bedaquiline donation program, will be conducted on April 14, 2015 at 8:00 am EST and can be accessed here.
Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)
The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.
How to access the bedaquiline donation program: step by step (post with simple image)
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
WHO report finds systems to combat antibiotic resistance lacking (post with simple image)
This survey is the first to capture governments’ own assessments of their response to resistance to antimicrobial medicines used to treat conditions such as bloodstream infections, pneumonia, tuberculosis, malaria and HIV.
MSF response to announcement of Otsuka’s donation programme for the TB drug delamanid (post with simple image)
MSF continues to express concern over the use of limited-scope donation programmes as a primary means of providing access to new TB drugs in countries affected by drug-resistant TB, as they are not a long-term solution to facilitating scale-up of treatment.
Page 62 of 70 · Total posts: 0←First 61 62 63 Last→